Literature DB >> 8621481

Dissecting clot retraction and platelet aggregation. Clot retraction does not require an intact fibrinogen gamma chain C terminus.

M M Rooney1, L V Parise, S T Lord.   

Abstract

Fibrinogen mediates the processes of platelet aggregation and clot retraction. Previous studies have demonstrated that fibrinogen binding to the platelet receptor alphaIIbbeta3 requires the C-terminal residues of the fibrinogen gamma chain. We made a recombinant human fibrinogen that lacks the gamma chain C-terminal four residues (AGDV). As expected this fibrinogen did not support platelet aggregation. Unexpectedly, this variant did support clot retraction that was indistinguishable from retraction with normal recombinant or plasma fibrinogen. These results suggest that the site on fibrinogen that is required for platelet aggregation differs from the site on fibrin that is required for clot retraction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621481     DOI: 10.1074/jbc.271.15.8553

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Time and force dependence of the rupture of glycoprotein IIb-IIIa-fibrinogen bonds between latex spheres.

Authors:  H L Goldsmith; F A McIntosh; J Shahin; M M Frojmovic
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

2.  Integrin alphaIIbbeta3:ligand interactions are linked to binding-site remodeling.

Authors:  Roy R Hantgan; Mary C Stahle; John H Connor; David A Horita; Mattia Rocco; Mary A McLane; Sergiy Yakovlev; Leonid Medved
Journal:  Protein Sci       Date:  2006-08       Impact factor: 6.725

3.  Species differences in small molecule binding to alpha IIb beta 3 are the result of sequence differences in 2 loops of the alpha IIb beta propeller.

Authors:  Ramesh B Basani; Hua Zhu; Michael A Thornton; Cinque S Soto; William F Degrado; M Anna Kowalska; Joel S Bennett; Mortimer Poncz
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

4.  The interaction of integrin αIIbβ3 with fibrin occurs through multiple binding sites in the αIIb β-propeller domain.

Authors:  Nataly P Podolnikova; Sergiy Yakovlev; Valentin P Yakubenko; Xu Wang; Oleg V Gorkun; Tatiana P Ugarova
Journal:  J Biol Chem       Date:  2013-12-12       Impact factor: 5.157

5.  Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies.

Authors:  Christian A Di Buduo; Lindsay S Wray; Lorenzo Tozzi; Alessandro Malara; Ying Chen; Chiara E Ghezzi; Daniel Smoot; Carla Sfara; Antonella Antonelli; Elise Spedden; Giovanna Bruni; Cristian Staii; Luigi De Marco; Mauro Magnani; David L Kaplan; Alessandra Balduini
Journal:  Blood       Date:  2015-01-09       Impact factor: 22.113

Review 6.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

7.  αIIbβ3 binding to a fibrinogen fragment lacking the γ-chain dodecapeptide is activation dependent and EDTA inducible.

Authors:  Hina Zafar; Yi Shang; Jihong Li; George A David; Joseph P Fernandez; Henrik Molina; Marta Filizola; Barry S Coller
Journal:  Blood Adv       Date:  2017-02-22

8.  Activation of integrin-beta3-associated syk in platelets.

Authors:  S Sarkar; M M Rooney; S T Lord
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

9.  PROBING αIIbβ3: LIGAND INTERACTIONS BY DYNAMIC FORCE SPECTROSCOPY AND SURFACE PLASMON RESONANCE.

Authors:  Roy R Hantgan; Martin Guthold; Samrat Dutta; David A Horita
Journal:  Nano Life       Date:  2013

10.  Roles of IL-6-gp130 Signaling in Vascular Inflammation.

Authors:  Tieying Hou; Brian C Tieu; Sutapa Ray; Adrian Recinos Iii; Ruwen Cui; Ronald G Tilton; Allan R Brasier
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.